Illumina Stock May Benefit From New Agreement to Acquire SomaLogicZacks Investment Research • 06/26/25
Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategyPRNewsWire • 06/23/25
Infinity Bio Closes $8M Series A Financing Led by Illumina Ventures to Expand Leadership in Antibody Reactome ProfilingBusiness Wire • 06/18/25
lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomicsPRNewsWire • 06/10/25
Illumina Introduces a New AI algorithm PromoterAI: Stock to Gain?Zacks Investment Research • 05/30/25
Illumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosisPRNewsWire • 05/29/25
Illumina, Inc. (ILMN) Bernstein 41st Annual Strategic Decisions Conference (Transcript)Seeking Alpha • 05/29/25
Illumina's TSO Comprehensive Earns Japan's Approval: Stock to Gain?Zacks Investment Research • 05/28/25
Illumina expands clinical oncology portfolio unlocking new standard of care and access to precision therapiesPRNewsWire • 05/28/25
Illumina Stock to Gain From the Launch of New DRAGEN v4.4 SoftwareZacks Investment Research • 05/20/25
Signios Bio and Illumina Announce Grant to Maximize Discovery Power with Industry's Largest NGS-Based Proteomics PanelBusiness Wire • 05/19/25
Icahn Ramps Up Bets On Genes And Jets: Illumina Stake Jumps 450%, JetBlue Holding Grow 90%Benzinga • 05/16/25
Investing in Illumina (ILMN)? Don't Miss Assessing Its International Revenue TrendsZacks Investment Research • 05/13/25
Illumina DRAGEN v4.4 powers clinical oncology research and multiomic applicationsPRNewsWire • 05/13/25
Illumina Q1 Earnings Top Estimates, Revenues Down Y/Y, Stock DipsZacks Investment Research • 05/09/25
Unveiling Illumina (ILMN) Q1 Outlook: Wall Street Estimates for Key MetricsZacks Investment Research • 05/05/25
Illumina and Ovation.io launching first-of-kind GLP-1 dataset to accelerate new therapy developmentPRNewsWire • 05/01/25
Target Validation for Genetic Targets Innovation Research Report 2025: 14,172 Deals Totaling $11.4 Billion - BGI biotech and illumina are Among the Leaders with Strong PortfoliosGlobeNewsWire • 04/18/25